share_log

Cantor Fitzgerald Reiterates Overweight on Spero Therapeutics

Moomoo 24/7 ·  Apr 4 09:45

Cantor Fitzgerald analyst Louise Chen reiterates Spero Therapeutics (NASDAQ:SPRO) with a Overweight.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment